Document is current
Any future updates will be listed below
-
Authors
Atzori, Marta
Fabbretti, Elsa
Ciraci, Viviana
Zucchelli, Silvia
Bon, Carlotta
Mikašinović, Sanja
Baj, Gabriele
Gustincich, Stefano
Tongiorgi, Enrico https://orcid.org/0000-0003-0485-0603
-
Funding
Funding for this research was provided by:
Università degli Studi di Trieste
- License Information
-
More Information
Article History
Received: 11 August 2025
Revised: 3 March 2026
Accepted: 4 March 2026
First Online: 14 March 2026
Declarations
:
: EF, ET, VC and SG and are co-inventor in the patent ITALIA N. 102023000026952 with international extension PCT/IB2024/062610, covering the use of SINEUPs to increase BDNF expression for any commercial and therapeutic purposes, including BDNF industrial protein production and gene-therapy use. SG is co-inventor in a patent on the use of SINEUPs for therapy.
